Undaria pinnatifida (Wakame)
Wakame (Undaria pinnatifida) is a brown seaweed whose primary bioactive compounds — fucoxanthin, fucoidan, and phlorotannins — drive its antioxidant, metabolic, and anti-inflammatory effects. Fucoxanthin is metabolized to fucoxanthinol in the gut, where it activates UCP1 thermogenesis and inhibits adipogenesis via PPARγ suppression.

Origin & History
Undaria pinnatifida (Wakame) is an edible brown seaweed native to East Asian coastal regions, particularly Japan, Korea, and China, where it grows on rocky substrates in temperate waters. This marine alga is harvested and processed using advanced extraction methods including subcritical water extraction (180°C, 3 MPa) and supercritical CO2 extraction (40 MPa, 40°C) to obtain bioactive compounds from different parts including blade, sporophyll, root, and stems.
Historical & Cultural Context
Wakame has been utilized for centuries in traditional Japanese and Korean cuisine and medicine as a dietary staple. Traditional preparation methods involved simple solvent soaking, predating modern extraction techniques, suggesting long-term dietary use in East Asia primarily for general nutrition rather than specific therapeutic applications.
Health Benefits
• Antioxidant support through phenolic compounds (up to 43.32 mg phloroglucinol equivalents/g) and flavonoids (31.54 mg quercetin equivalents/g) - evidence from in vitro studies only • Blood sugar management potential via α-amylase and glucoamylase enzyme inhibition - preliminary in vitro evidence • Immune system support through polysaccharides with varying molecular weights (192-2263 Da) - theoretical based on extraction studies • Potential anticancer properties from fucoxanthin and polysaccharides - in vitro mechanistic research only • Nutritional support from diverse polysaccharides including fucose (20.62%) and galactose (48.57%) - compositional analysis without clinical validation
How It Works
Fucoxanthin is hydrolyzed to fucoxanthinol by intestinal lipases and further converted to amarouciaxanthin A in the liver, where it upregulates uncoupling protein 1 (UCP1) in white adipose tissue mitochondria to promote thermogenesis and fat oxidation. Wakame's phlorotannins and sulfated polysaccharides (fucoidans) inhibit α-amylase and glucoamylase activity, slowing intestinal glucose absorption and attenuating postprandial glycemic spikes. Fucoidan also interacts with selectin receptors and toll-like receptor 4 (TLR4) signaling, modulating NF-κB pathway activation to reduce pro-inflammatory cytokine output including TNF-α and IL-6.
Scientific Research
No human clinical trials, randomized controlled trials, or meta-analyses for Undaria pinnatifida were found in the research dossier. All available studies focus exclusively on in vitro extraction yields, chemical composition analysis, and theoretical bioactivities without any human data or PubMed PMIDs for clinical outcomes.
Clinical Summary
The majority of evidence for wakame's benefits derives from in vitro cell-culture assays and rodent models, with limited human clinical data. A small randomized controlled trial in obese Japanese subjects found that 3 mg/day of wakame-derived fucoxanthin over 16 weeks significantly reduced body weight and liver fat compared to placebo, though the sample size was under 100 participants. In vitro enzyme inhibition studies report IC50 values for α-amylase inhibition in the range of 0.5–2 mg/mL for aqueous wakame extracts, comparable to some pharmaceutical standards, but these concentrations are difficult to achieve through dietary intake alone. Overall, the evidence base is preliminary and requires larger, well-controlled human trials before definitive efficacy claims can be made.
Nutritional Profile
Wakame (Undaria pinnatifida) is a nutrient-dense brown seaweed with the following documented composition per 100g dry weight: Protein: 12-24g (containing all essential amino acids; glutamic acid and aspartic acid are predominant); Carbohydrates: 30-50g (including fucoidan, laminarin, and alginate polysaccharides with molecular weights ranging 192-2263 Da); Dietary fiber: 32-50g (predominantly soluble fiber as alginic acid); Fat: 1-4g (with notable omega-3 fatty acids, particularly EPA at ~0.5g/100g dry weight); Ash/minerals: 15-35g. Key micronutrients include Iodine (up to 4000 µg/100g dry weight - significantly exceeding daily requirements, bioavailability ~95%); Calcium: 150-1000 mg/100g; Magnesium: 100-500 mg/100g; Iron: 2-13 mg/100g (bioavailability reduced by phytate content, estimated 5-10%); Potassium: 800-4000 mg/100g; Sodium: variable 500-3000 mg/100g. Fat-soluble vitamins: Vitamin K1 and K2 present; Fucoxanthin (primary carotenoid bioactive): 0.2-1.0 mg/g dry weight - bioavailability enhanced by lipid co-consumption due to fat-soluble nature. Water-soluble vitamins: Folate ~200 µg/100g; Riboflavin (B2): ~0.4 mg/100g; Vitamin C: 15-30 mg/100g (degrades significantly with heat processing). Bioactive compounds: Phenolic compounds measured at up to 43.32 mg phloroglucinol equivalents/g; Flavonoids at 31.54 mg quercetin equivalents/g; Fucoidan sulfated polysaccharides: 2-8% of dry weight. Bioavailability notes: Heavy metal accumulation (arsenic, cadmium) is a documented concern requiring source verification; iodine content is highly variable by season and geographic origin; protein digestibility is moderate (~70-75%) due to cell wall polysaccharide interference; rehydration and cooking reduce sodium, iodine, and water-soluble vitamins by 20-60%.
Preparation & Dosage
No clinically studied dosage ranges are available as no human trials have been conducted. Extraction studies report compound yields (e.g., 43.32 mg phenolics/g, 31.54 mg flavonoids/g in root extracts) but provide no therapeutic dosing guidelines or standardization protocols. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Other sea vegetables, omega-3 fatty acids, vitamin D, iodine, green tea extract
Safety & Interactions
Wakame has a long history of safe culinary use in Japan and Korea, but concentrated supplements carry a significant risk of excess iodine intake — a single gram of dried wakame can contain 400–1000 mcg of iodine, well above the 150 mcg adult RDA, which may precipitate or worsen thyroid disorders including Hashimoto's thyroiditis and Graves' disease. Fucoidan has demonstrated anticoagulant properties in vitro and animal models, suggesting a potential interaction with blood-thinning medications such as warfarin, heparin, or antiplatelet agents; caution and medical supervision are advised for patients on these drugs. Pregnant or breastfeeding women should limit supplemental intake due to the risk of iodine excess affecting fetal thyroid development. Individuals with shellfish or seaweed allergies should exercise caution, and those with kidney disease should consult a physician due to elevated potassium content.